0001209191-24-001146.txt : 20240108 0001209191-24-001146.hdr.sgml : 20240108 20240108163904 ACCESSION NUMBER: 0001209191-24-001146 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240104 FILED AS OF DATE: 20240108 DATE AS OF CHANGE: 20240108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Silberman David CENTRAL INDEX KEY: 0001867998 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35813 FILM NUMBER: 24520688 MAIL ADDRESS: STREET 1: 20 MAMILLA AVENUE CITY: JERUSALEM STATE: L3 ZIP: 9414904 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ORAMED PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0001176309 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 980376008 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 646-844-1164 MAIL ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: Integrated Security Technologies, Inc. DATE OF NAME CHANGE: 20040614 FORMER COMPANY: FORMER CONFORMED NAME: IGUANA VENTURES LTD DATE OF NAME CHANGE: 20020625 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2024-01-04 0 0001176309 ORAMED PHARMACEUTICALS INC. ORMP 0001867998 Silberman David 20 MAMILLA AVENUE JERUSALEM L3 9414904 ISRAEL 0 1 0 0 Chief Financial Officer 0 Common Stock 2024-01-04 4 A 0 136500 A 366500 D Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 11,375 over a three year period starting January 8, 2024. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. /s/ David Silberman 2024-01-08